文献速递创伤与烧伤复苏、休克与脓毒症

失血对猪模型中氨甲环酸药代动力学的影响

The effects of hemorrhage on the pharmacokinetics of tranexamic acid in a swine model.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论猪模型显示,按2017年联合创伤系统临床实践指南剂量给药后1小时内输注一个血容量,约25%的氨甲环酸剂量可因失血丢失,最低血浆浓度34 μg/mL。

该研究为前瞻性实验研究,先在体外评估氨甲环酸的血浆-细胞分配,再用尤卡坦小型猪进行体内建模。正常血容量组与低血容量组(血容量减少35%)各4头猪接受1 g静脉氨甲环酸,4小时内14个时间点采血测定清除率。另4头猪失血35%后,先以15 mg/kg输注10分钟、再以1.875 mg/kg每小时输注模拟大量出血场景,第一小时内失血一个总血容量并同步以不含氨甲环酸的血替代,系列采血及失血血样分析显示平均25%的剂量经失血丢失,交换输血期间最低血浆浓度为34 μg/mL。

要点

  • 低血容量组氨甲环酸清除率低于正常血容量组(70 ± 7 vs 115 ± 4 mL/min)。
  • 失血35%后按15 mg/kg输注10分钟继以1.875 mg/kg每小时输注,第一小时内失血一个总血容量并同步以不含氨甲环酸的血替代,平均25%的剂量经失血丢失。
  • 交换输血期间最低血浆氨甲环酸浓度为34 μg/mL。
  • 作者认为,若在启动治疗后1小时内输注一个血容量,2017年联合创伤系统临床实践指南剂量的氨甲环酸平均25%可因失血丢失。
  • 作者建议开发并测试补充策略,寻找简单方法调整现行剂量指南以维持治疗性血浆浓度。

适用人群与场景

  • 尤卡坦小型猪(Yucatan minipigs),用于模拟可能需要大量输血的失血场景。

处置流程与药物剂量

  • 低血容量建模:失血35%血容量。
  • 大量出血模拟方案:氨甲环酸15 mg/kg静脉输注10分钟,随后以1.875 mg/kg每小时持续输注。
  • 给药第一小时内失血一个总血容量,并同步以不含氨甲环酸的血替代。

研究设计与关键结果

  • 研究类型:前瞻性实验研究,尤卡坦小型猪模型;体外部分评估氨甲环酸血浆-细胞分配,体内部分比较正常血容量与低血容量(血容量减少35%)各4头猪接受1 g静脉氨甲环酸后4小时内14个时间点的清除率。
  • 低血容量组氨甲环酸清除率低于正常血容量组(70 ± 7 vs 115 ± 4 mL/min)。
  • 另4头猪失血35%血容量后按15 mg/kg输注10分钟继以1.875 mg/kg每小时输注,第一小时内失血一个总血容量并以不含氨甲环酸的血同步替代,平均25%的剂量经失血丢失。
  • 交换输血期间最低血浆氨甲环酸浓度为34 μg/mL。

证据类型、等级与局限

  • 证据类型:前瞻性实验研究(猪模型)。
  • 证据等级:治疗性,II级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,若在启动氨甲环酸治疗后1小时内输注一个血容量,2017年联合创伤系统临床实践指南剂量的氨甲环酸平均25%可因失血丢失。
  • 作者建议开发并测试补充策略,寻找简单方法调整现行剂量指南以维持治疗性血浆浓度。

指南或共识出处

  • 2017年联合创伤系统临床实践指南(Joint Trauma System Clinical Practice Guideline)

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The early use of tranexamic acid (TXA) is strongly advocated in patients who are likely to require massive transfusion to decrease mortality. This study determines the influence of hemorrhage on the pharmacokinetics of TXA in a porcine model.

METHODS: The investigation was a prospective experimental study in Yucatan minipigs. First, in vitro plasma-cell partitioning of TXA was evaluated by inoculating whole blood with known aliquots, centrifuging, and measuring the supernatant with high-performance liquid chromatography with mass spectrometry (HPLC-MS). Then, using in vivo modeling, normovolemic and hypovolemic (35% reduction in blood volume) swine (n = 4 per group) received 1 g of intravenous TXA and had blood sampled at 14 time points over 4 hours to determine baseline clearance via HPLC-MS. Additional swine (n = 4) were hemorrhaged 35% of their blood volume, and TXA was administered as a 15 mg/kg infusion over 10 minutes followed by infusion of 1.875 mg/kg per hour to simulate massive hemorrhage scenario. During the first hour of TXA administration, one total blood volume was hemorrhaged and simultaneously replaced with TXA free blood. Serial blood samples and the hemorrhaged blood were analyzed by HPLC-MS to determine the percentage of dose lost via hemorrhage.

RESULTS: Clearance of TXA was diminished in the hypovolemic group compared with the normovolemic group (115 ± 4 vs 70 ± 7 mL/min). Percentage of dose lost via hemorrhage averaged 25%. The lowest measured plasma level during the exchange transfusion was 34 μg/mL.

CONCLUSION: Mean 25% of the present 2017 Joint Trauma System Clinical Practice Guideline dosing of TXA can be lost to hemorrhage if a blood volume is transfused within an hour of initiating therapy. In the case of TXA, which has limited distribution and is administered during active hemorrhage and massive blood transfusions, replacement strategies should be developed and tested to find simple methods of adjusting the current dosing guidelines to maintain therapeutic plasma concentrations.

LEVEL OF EVIDENCE: Therapeutic, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Derickson MJ, McClellan JM, Marko ST, et al. The effects of hemorrhage on the pharmacokinetics of tranexamic acid in a swine model. J Trauma Acute Care Surg. 2018. PMID: 29953031. doi:10.1097/TA.0000000000001861

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。